Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB26FT0RC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is unset-aside and competitively awarded, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location and an ultimate completion date of December 1, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a critical role in the federal medical supply chain through its extensive portfolio of pharmaceutical products and medical supplies. The company's DLA IDC encompasses brand-name and generic medications, vaccines, specialty drugs, and medical devices across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for Skyrizi, a specialty pharmaceutical product, exemplifies the company's ongoing fulfillment of federal medical procurement requirements through firm fixed-price arrangements with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DB26FT0RC?
SPE2DB26FT0RC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FT0RC worth?
The government has obligated $11,830 on SPE2DB26FT0RC.
Is contract SPE2DB26FT0RC an order under another contract?
Yes. SPE2DB26FT0RC is a delivery order under SPE2DB22D3401, an indefinite delivery contract.
Was contract SPE2DB26FT0RC competed?
The extent of competition for SPE2DB26FT0RC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award